8-K Announcements
6Material company update
May 7, 2026·SEC
Material company update
Feb 26, 2026·SEC
Material company update
Dec 8, 2025·SEC
Privia Health Group, Inc.(PRVA)Earnings, Financials & Key Ratios
PRVA•NASDAQ
131.5× P/E·Price updated Jun 19, 2026
AboutPrivia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.Show more
- Revenue$2.12B+22.3%
- EBITDA$44M+82.0%
- Net Income$23M+59.3%
- EPS (Diluted)0.18+63.6%
- Gross Margin9.87%-3.1%
- EBITDA Margin2.08%+48.9%
- Operating Margin1.61%+64.9%
- Net Margin1.08%+30.3%
- ROE3.11%+39.5%
PRVA Key Insights
Privia Health Group, Inc. (PRVA) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 21.0%
- ✓Efficient asset utilization: 1.6x turnover
✗Weaknesses
- ✗Weak 3Y average ROE of 3.1%
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when PRVA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
PRVA Price & Volume
Privia Health Group, Inc. (PRVA) stock price & volume — 10-year historical chart
Loading chart...
PRVA Growth Metrics
Privia Health Group, Inc. (PRVA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years21.04%
3 Years16.1%
TTM24.72%
Profit CAGR
10 Years-
5 Years-6.01%
3 Years-
TTM39.32%
EPS CAGR
10 Years-
5 Years-9.71%
3 Years-
TTM34.46%
Return on Capital
10 Years-3.74%
5 Years-11.41%
3 Years3.61%
Last Year4.6%
PRVA Recent Earnings
Privia Health Group, Inc. (PRVA) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 1/12 qtrs (8%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 7, 2026Metric
Actual
Est
EPS
$0.02-75.0%
$0.08
Rev
$604M+7.6%
$561M
Q1 2026
Feb 26, 2026Metric
Actual
Est
EPS
$0.07+75.0%
$0.04
Rev
$541M+4.8%
$516M
Q4 2025
Nov 6, 2025Metric
Actual
Est
EPS
$0.05-16.7%
$0.06
Rev
$580M+12.4%
$517M
Q3 2025
Aug 7, 2025Metric
Actual
Est
EPS
$0.02-60.0%
$0.05
Rev
$521M+7.3%
$486M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $0.02vs $0.08-75.0% | $604Mvs $561M+7.6% |
| Q1 2026 | Feb 26, 2026 | $0.07vs $0.04+75.0% | $541Mvs $516M+4.8% |
| Q4 2025 | Nov 6, 2025 | $0.05vs $0.06-16.7% | $580Mvs $517M+12.4% |
| Q3 2025 | Aug 7, 2025 | $0.02vs $0.05-60.0% | $521Mvs $486M+7.3% |
Based on last 12 quarters of dataView full earnings history →
PRVA Peer Comparison
Privia Health Group, Inc. (PRVA) competitors in Care Delivery Networks and Value-Based Care — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 AGIO | 2.03B | 34.16 | -4.80 | 48.03% | -6.4% | -34.11% | 0.05 | |
 CNC | 30.13B | 61.02 | -4.48 | 19.44% | -3.25% | -28.6% | 0.94 | |
 ALHC | 4.47B | 21.86 | -5908.11 | 46.06% | 0.47% | 11.5% | 1.89 | |
 OSCR | 7.36B | 28.40 | -16.80 | 27.5% | -0.3% | -3.26% | 0.44 | |
 DOCS | 3.83B | 20.46 | 20.88 | 13.05% | 30.4% | 19.36% | 0.01 | |
 WELL | 144.78B | 206.65 | 148.67 | 35.82% | 12.31% | 3.49% | 0.49 | |
 UNH | 363.94B | 400.96 | 30.31 | 11.81% | 2.68% | 11.54% | 0.77 | |
 CVS | 125.45B | 98.32 | 70.73 | 7.85% | 0.72% | 3.86% | 1.24 |
Compare PRVA vs Peers
Privia Health Group, Inc. (PRVA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
PRVA Income Statement
Privia Health Group, Inc. (PRVA) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 657.61M | 786.36M | 817.08M | 966.22M | 1.36B | 1.66B | 1.74B | 2.12B | 2.25B |
Revenue Growth % | - | 19.58% | 3.91% | 18.25% | 40.41% | 22.19% | 4.74% | 22.26% | 24.72% |
Cost of Goods Sold | 601.15M | 717.89M | 734.49M | 902.56M | 1.22B | 1.5B | 1.56B | 1.91B | 2.03B |
COGS % of Revenue | 91.41% | 91.29% | 89.89% | 93.41% | 90.07% | 90.26% | 89.81% | 90.13% | - |
Gross Profit | 56.46M▲ 0% | 68.47M▲ 21.3% | 82.58M▲ 20.6% | 63.66M▼ 22.9% | 134.78M▲ 111.7% | 161.5M▲ 19.8% | 176.85M▲ 9.5% | 209.43M▲ 18.4% | 215.35M▲ 0% |
Gross Margin % | 8.59% | 8.71% | 10.11% | 6.59% | 9.93% | 9.74% | 10.19% | 9.87% | 9.59% |
Gross Profit Growth % | - | 21.28% | 20.61% | -22.91% | 111.72% | 19.82% | 9.51% | 18.42% | - |
Operating Expenses | 54.3M | 52.41M | 57.2M | 281.1M | 153.9M | 140.85M | 159.87M | 175.19M | 178.91M |
OpEx % of Revenue | 8.26% | 6.66% | 7% | 29.09% | 11.34% | 8.5% | 9.21% | 8.25% | - |
Selling, General & Admin | 53.23M | 50.98M | 55.36M | 278.63M | 149.33M | 134.32M | 152.6M | 165.29M | 49.73B |
SG&A % of Revenue | 8.1% | 6.48% | 6.78% | 28.84% | 11.01% | 8.1% | 8.79% | 7.79% | - |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R&D % of Revenue | - | - | - | - | - | - | - | - | - |
Other Operating Expenses | 1.07M | 1.43M | 1.84M | 2.46M | 4.57M | 6.53M | 7.27M | 9.91M | 0 |
Operating Income | 2.15M▲ 0% | 16.06M▲ 645.3% | 25.38M▲ 58.0% | -217.44M▼ 956.7% | -19.12M▲ 91.2% | 20.65M▲ 208.0% | 16.98M▼ 17.8% | 34.23M▲ 101.6% | 36.44M▲ 0% |
Operating Margin % | 0.33% | 2.04% | 3.11% | -22.5% | -1.41% | 1.25% | 0.98% | 1.61% | 1.62% |
Operating Income Growth % | - | 645.34% | 58.01% | -956.72% | 91.21% | 207.99% | -17.76% | 101.6% | - |
EBITDA | 3.23M | 17.49M | 27.22M | -214.97M | -14.55M | 27.18M | 24.25M | 44.14M | 47.73M |
EBITDA Margin % | 0.49% | 2.22% | 3.33% | -22.25% | -1.07% | 1.64% | 1.4% | 2.08% | 2.12% |
EBITDA Growth % | - | 442.29% | 55.66% | -889.67% | 93.23% | 286.81% | -10.79% | 82.03% | 66.15% |
D&A (Non-Cash Add-back) | 1.07M | 1.43M | 1.84M | 2.46M | 4.57M | 6.53M | 7.27M | 9.91M | 11.29M |
EBIT | 2.15M | 16.06M | 25.38M | -217.44M | -19.12M | 20.65M | 16.98M | 34.23M | 41.12M |
Net Interest Income | -6.42M | -6.91M | -1.92M | -1.07M | 542K | 8.37M | 10.89M | 9.7M | 8.66M |
Interest Income | 0 | 0 | 0 | 0 | 542K | 8.37M | 10.89M | 9.7M | 8.66M |
Interest Expense | 6.42M | 6.91M | 1.92M | 1.07M | 0 | 0 | 0 | 0 | 0 |
Other Income/Expense | -6.42M | -6.91M | -1.92M | -1.07M | 542K | 8.37M | 10.89M | 9.7M | 8.66M |
Pretax Income | -4.26M▲ 0% | 9.15M▲ 314.6% | 23.46M▲ 156.4% | -218.51M▼ 1031.3% | -18.58M▲ 91.5% | 29.02M▲ 256.2% | 27.87M▼ 4.0% | 43.94M▲ 57.7% | 45.1M▲ 0% |
Pretax Margin % | -0.65% | 1.16% | 2.87% | -22.61% | -1.37% | 1.75% | 1.61% | 2.07% | 2.01% |
Income Tax | -76K | 1.21M | -7.44M | -27.86M | -6.52M | 7.99M | 10.83M | 14.21M | 17.71M |
Effective Tax Rate % | 1.78% | 13.19% | -31.71% | 12.75% | 35.07% | 27.54% | 38.84% | 32.35% | 39.27% |
Net Income | -3.04M▲ 0% | 8.24M▲ 370.8% | 31.24M▲ 279.0% | -188.23M▼ 702.5% | -8.59M▲ 95.4% | 23.08M▲ 368.8% | 14.38M▼ 37.7% | 22.92M▲ 59.3% | 21.76M▲ 0% |
Net Margin % | -0.46% | 1.05% | 3.82% | -19.48% | -0.63% | 1.39% | 0.83% | 1.08% | 0.97% |
Net Income Growth % | - | 370.83% | 278.99% | -702.45% | 95.44% | 368.83% | -37.67% | 59.33% | 39.32% |
Net Income (Continuing) | -4.19M | 7.95M | 30.9M | -190.65M | -12.06M | 21.03M | 17.04M | 29.73M | 27.39M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | -2.46M | -2.76M | -3.1M | 23.31M | 19.95M | 45.95M | 48.26M | 53.73M | 52.84B |
EPS (Diluted) | -0.03▲ 0% | 0.08▲ 363.5% | 0.30▲ 284.6% | -1.77▼ 690.0% | -0.08▲ 95.6% | 0.19▲ 344.8% | 0.11▼ 42.1% | 0.18▲ 63.6% | 0.17▲ 0% |
EPS Growth % | - | 363.51% | 284.62% | -690% | 95.62% | 344.85% | -42.11% | 63.64% | 34.46% |
EPS (Basic) | -0.03 | 0.08 | 0.30 | -1.77 | -0.08 | 0.20 | 0.12 | 0.19 | - |
Diluted Shares Outstanding | 102.79M | 105.71M | 105.71M | 107.84M | 110.7M | 124.69M | 125.61M | 128.89M | 130.88M |
Basic Shares Outstanding | 102.79M | 105.71M | 105.71M | 107.84M | 110.7M | 116.73M | 119.4M | 122.18M | 124.15M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
PRVA Balance Sheet
Privia Health Group, Inc. (PRVA) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 115.49M | 129.6M | 190.08M | 446.68M | 551.96M | 700.8M | 834.82M | 911M | 966.02B |
Cash & Short-Term Investments | 39.11M | 46.89M | 84.63M | 320.58M | 347.99M | 389.51M | 491.15M | 479.69M | 479.69M |
Cash Only | 39.11M | 46.89M | 84.63M | 320.58M | 347.99M | 389.51M | 491.15M | 479.69M | 479.69M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 71.16M | 77.34M | 99.12M | 117.4M | 189.6M | 290.77M | 316.18M | 400.9M | 513.68B |
Days Sales Outstanding | 39.5 | 35.9 | 44.28 | 44.35 | 51.01 | 64.02 | 66.46 | 68.93 | 20.92K |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | - | - | - | - | - | - | - | - | - |
Other Current Assets | 0 | 0 | 0 | 0 | 14.37M | 20.52M | 27.5M | 30.41M | 32.82B |
Total Non-Current Assets | 134M | 140.61M | 138.88M | 239.7M | 240.85M | 299.1M | 300.96M | 458.38M | 451.87B |
Property, Plant & Equipment | 698K | 5.62M | 4.81M | 14.14M | 11.47M | 8.94M | 6.07M | 9.3M | 8.69B |
Fixed Asset Turnover | 942.13x | 139.87x | 169.73x | 68.35x | 118.23x | 185.49x | 286.06x | 228.31x | 1.03x |
Goodwill | 118.66M | 118.66M | 118.66M | 127.94M | 126.94M | 138.75M | 141.62M | 209.84M | 209.84B |
Intangible Assets | 7.26M | 6.62M | 5.98M | 59.74M | 57.39M | 107.63M | 109.81M | 215.92M | 212.78B |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 7.37M | 9.7M | 4.47M | 4.52M | 4.68M | 8.58M | 17.09M | 21.04M | 20.55B |
Total Assets | 249.49M▲ 0% | 270.2M▲ 8.3% | 328.97M▲ 21.7% | 686.37M▲ 108.6% | 792.81M▲ 15.5% | 999.9M▲ 26.1% | 1.14B▲ 13.6% | 1.37B▲ 20.6% | 1.42T▲ 0% |
Asset Turnover | 2.64x | 2.91x | 2.48x | 1.41x | 1.71x | 1.66x | 1.53x | 1.55x | 0.01x |
Asset Growth % | - | 8.31% | 21.75% | 108.64% | 15.51% | 26.12% | 13.59% | 20.57% | 119757.73% |
Total Current Liabilities | 101.32M | 115.22M | 146.94M | 190.46M | 264.27M | 386.95M | 449.15M | 568.52M | 601.3B |
Accounts Payable | 4.67M | 525K | 5.24M | 2.97M | 6.73M | 7.88M | 9.76M | 7.97M | 529.28M |
Days Payables Outstanding | 2.83 | 0.27 | 2.6 | 1.2 | 2.01 | 1.92 | 2.28 | 1.52 | 47.27 |
Short-Term Debt | 7.13M | 3.38M | 875K | 875K | 0 | 0 | 0 | 0 | 2.11B |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 4.39M | 86.86M | 112.98M | 148.2M | 214.6M | 332.05M | 370.61M | 503.07M | 598.65B |
Current Ratio | 1.14x | 1.12x | 1.29x | 2.35x | 2.09x | 1.81x | 1.86x | 1.60x | 1.61x |
Quick Ratio | 1.14x | 1.12x | 1.29x | 2.35x | 2.09x | 1.81x | 1.86x | 1.60x | 1.61x |
Cash Conversion Cycle | - | - | - | - | - | - | - | - | 20.87K |
Total Non-Current Liabilities | 62.12M | 47.53M | 38.38M | 45.73M | 9.49M | 5.56M | 3.19M | 9.91M | 10.69B |
Long-Term Debt | 59.87M | 39.73M | 32.78M | 31.69M | 0 | 0 | 0 | 0 | 6.91B |
Capital Lease Obligations | 0 | 0 | 0 | 11.04M | 8.49M | 5.25M | 3.04M | 7.33M | 22.05M |
Deferred Tax Liabilities | 0 | 2.88M | 0 | 0 | 0 | 0 | 0 | 0 | 254M |
Other Non-Current Liabilities | 2.25M | 4.92M | 5.59M | 3M | 1M | 313K | 153K | 2.58M | 3.53B |
Total Liabilities | 163.44M | 162.75M | 185.32M | 236.19M | 273.76M | 392.51M | 452.34M | 578.43M | 611.99B |
Total Debt | 67M | 43.1M | 33.66M | 46.5M | 11.5M | 8.29M | 5.59M | 9.53M | 9.02B |
Net Debt | 27.89M | -3.79M | -50.97M | -274.08M | -336.49M | -381.22M | -485.56M | -470.15M | 8.54B |
Debt / Equity | 0.78x | 0.40x | 0.23x | 0.10x | 0.02x | 0.01x | 0.01x | 0.01x | 0.01x |
Debt / EBITDA | 20.78x | 2.46x | 1.24x | - | - | 0.30x | 0.23x | 0.22x | 189.02x |
Net Debt / EBITDA | 8.65x | -0.22x | -1.87x | - | - | -14.02x | -20.02x | -10.65x | 178.97x |
Interest Coverage | 0.34x | 2.32x | 13.24x | -203.21x | - | - | - | - | - |
Total Equity | 86.04M▲ 0% | 107.46M▲ 24.9% | 143.65M▲ 33.7% | 450.18M▲ 213.4% | 519.05M▲ 15.3% | 607.39M▲ 17.0% | 683.45M▲ 12.5% | 790.94M▲ 15.7% | 805.9B▲ 0% |
Equity Growth % | - | 24.89% | 33.68% | 213.38% | 15.3% | 17.02% | 12.52% | 15.73% | 113528.33% |
Book Value per Share | 0.84 | 1.02 | 1.36 | 4.17 | 4.69 | 4.87 | 5.44 | 6.14 | 6157.63 |
Total Shareholders' Equity | 88.5M | 110.21M | 146.75M | 426.87M | 499.09M | 561.44M | 635.18M | 737.22M | 753.06B |
Common Stock | 959K | 959K | 960K | 1.08M | 1.15M | 1.18M | 1.2M | 1.24M | 1.26B |
Retained Earnings | -59.37M | -51.12M | -19.88M | -208.11M | -216.69M | -193.61M | -179.23M | -156.31M | -153.25B |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | -2.46M | -2.76M | -3.1M | 23.31M | 19.95M | 45.95M | 48.26M | 53.73M | 52.84B |
PRVA Cash Flow Statement
Privia Health Group, Inc. (PRVA) cash flow — operating, investing & free cash flow history
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 5.25M | 24.36M | 38.89M | 55.06M | 47.2M | 80.78M | 109.28M | 163.4M | 138M |
Operating CF Margin % | 0.8% | 3.1% | 4.76% | 5.7% | 3.48% | 4.87% | 6.29% | 7.7% | - |
Operating CF Growth % | - | 364.05% | 59.66% | 41.57% | -14.28% | 71.17% | 35.28% | 49.53% | -55.17% |
Net Income | -4.19M | 7.95M | 30.9M | -190.65M | -12.06M | 23.08M | 14.38M | 22.92M | 21.76M |
Depreciation & Amortization | 1.07M | 1.43M | 1.83M | 2.46M | 4.57M | 6.53M | 7.27M | 9.91M | 11.29M |
Stock-Based Compensation | 1.94M | 207K | 484K | 253.53M | 67.36M | 0 | 0 | 0 | 18.85M |
Deferred Taxes | -258K | 716K | -7.83M | -28.41M | -7M | 7.46M | 8.82M | 10.87M | 11.69M |
Other Non-Cash Items | 147K | 332K | 134K | 157K | 687K | 35.05M | 59.34M | 75.42M | 58.92M |
Working Capital Changes | 6.54M | 13.73M | 13.37M | 17.97M | -6.35M | 8.66M | 19.47M | 44.29M | 14.9M |
Change in Receivables | 320K | -6.18M | -21.78M | -14.64M | -72.2M | -96.88M | -19.82M | -36.67M | -76.89M |
Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Payables | -983K | -4.14M | 4.71M | 0 | 6.85M | 118.36M | 52.85M | 14.82M | 25.86M |
Cash from Investing | -165K | -5.71M | -380K | -32.77M | -104K | -48.01M | -10.32M | -181.57M | -193.04M |
Capital Expenditures | -220K | -5.71M | -380K | -547K | -104K | -113K | -5.02M | -1.2M | -1.23M |
CapEx % of Revenue | 0.03% | 0.73% | 0.05% | 0.06% | 0.01% | 0.01% | 0.29% | 0.06% | 0.05% |
Acquisitions | 55K | 0 | 0 | -32.23M | 125K | -47.89M | -5.3M | -181.72M | -193.16M |
Investments | - | - | - | - | - | - | - | - | - |
Other Investing | 0 | 0 | 0 | 0 | -125K | 0 | 0 | 1.34M | 1.34M |
Cash from Financing | 15.36M | -10.87M | -767K | 213.66M | -19.68M | 8.74M | 2.68M | 6.7M | 5.23M |
Debt Issued (Net) | 15.25M | -10.87M | -875K | -875K | -33.25M | 0 | 0 | -2.46M | -2.46M |
Equity Issued (Net) | 0 | 0 | 0 | 223.69M | 13.45M | 8.74M | 2.68M | 8.05M | 6.58M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | 106K | 0 | 108K | -9.15M | 125K | 0 | 0 | 1.11M | 1.11M |
Net Change in Cash | 20.44M▲ 0% | 7.78M▼ 61.9% | 37.74M▲ 385.1% | 235.94M▲ 525.1% | 27.41M▼ 88.4% | 41.52M▲ 51.4% | 101.64M▲ 144.8% | -11.46M▼ 111.3% | -49.81M▲ 0% |
Free Cash Flow | 5.03M▲ 0% | 18.65M▲ 270.8% | 38.51M▲ 106.5% | 54.51M▲ 41.5% | 47.09M▼ 13.6% | 80.67M▲ 71.3% | 104.26M▲ 29.2% | 162.2M▲ 55.6% | 136.77M▲ 0% |
FCF Margin % | 0.76% | 2.37% | 4.71% | 5.64% | 3.47% | 4.87% | 6% | 7.64% | 6.09% |
FCF Growth % | - | 270.83% | 106.5% | 41.55% | -13.61% | 71.31% | 29.24% | 55.57% | 15.56% |
FCF per Share | 0.05 | 0.18 | 0.36 | 0.51 | 0.43 | 0.65 | 0.83 | 1.26 | 1.05 |
FCF Conversion (FCF/Net Income) | -1.72x | 2.95x | 1.24x | -0.29x | -5.50x | 3.50x | 7.60x | 7.13x | 6.28x |
Interest Paid | 3.72M | 9.2M | 1.93M | 888K | 713K | 0 | 0 | 0 | 0 |
Taxes Paid | 27K | 316K | 381K | 504K | 307K | 0 | 0 | 0 | 0 |
PRVA Key Ratios
Privia Health Group, Inc. (PRVA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 8.52% | 24.88% | -63.39% | -1.77% | 4.1% | 2.23% | 3.11% | 0.01% |
Return on Invested Capital (ROIC) | 11.07% | 19.39% | -121.35% | -8% | 7.58% | 6.01% | 9.9% | 0.01% |
Gross Margin | 8.71% | 10.11% | 6.59% | 9.93% | 9.74% | 10.19% | 9.87% | 9.59% |
Net Margin | 1.05% | 3.82% | -19.48% | -0.63% | 1.39% | 0.83% | 1.08% | 0.97% |
Debt / Equity | 0.40x | 0.23x | 0.10x | 0.02x | 0.01x | 0.01x | 0.01x | 0.01x |
Interest Coverage | 2.32x | 13.24x | -203.21x | - | - | - | - | - |
FCF Conversion | 2.95x | 1.24x | -0.29x | -5.50x | 3.50x | 7.60x | 7.13x | 6.28x |
Revenue Growth | 19.58% | 3.91% | 18.25% | 40.41% | 22.19% | 4.74% | 22.26% | 24.72% |
Related:PRVA Dividend History·PRVA Revenue History·PRVA Price History·PRVA P/E History·PRVA Financial Ratios·PRVA Institutional Holders
PRVA SEC Filings & Documents
Privia Health Group, Inc. (PRVA) SEC filings — annual & quarterly reports (10-K, 10-Q)
PRVA Frequently Asked Questions
Privia Health Group, Inc. (PRVA) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Privia Health Group, Inc. (PRVA) reported $2.25B in revenue for fiscal year 2025. This represents a 242% increase from $657.6M in 2018.
Privia Health Group, Inc. (PRVA) grew revenue by 22.3% over the past year. This is strong growth.
Yes, Privia Health Group, Inc. (PRVA) is profitable, generating $21.8M in net income for fiscal year 2025 (1.1% net margin).
Dividend & Returns
Privia Health Group, Inc. (PRVA) has a return on equity (ROE) of 3.1%. This is below average, suggesting room for improvement.
Privia Health Group, Inc. (PRVA) generated $136.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.